Cite

HARVARD Citation

    Adimadhyam, S. et al. (n.d.). S738 Real World Evidence Comparing Vedolizumab and Ustekinumab in Anti-TNF Experienced Patients With Crohn's Disease. American journal of gastroenterology. pp. e519-e520. [Online]. 
  
Back to record